Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 30;35(2):220-233.
doi: 10.31138/mjr.240224.cap. eCollection 2024 Jun.

Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases

Jan René Nkeck  1   2 , Ange Larissa Tchuisseu-Kwangoua  1   3 , Adeline Pelda  1   2   4 , Wilson Chia Tamko  1   2   4 , Saquinatou Hamadjoda  1   2   4 , Doris Bibi Essama  2 , Baudelaire Fojo  1   2   4 , Moustapha Niasse  5 , Saïdou Diallo  5 , Madeleine Ngandeu-Singwé  1   2   4
Affiliations
Review

Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases

Jan René Nkeck et al. Mediterr J Rheumatol. .

Abstract

Advances in knowledge of the microbiome and its relationship with the immune system have led to a better understanding of the pathogenesis of chronic inflammatory rheumatic diseases (CIRD). Indeed, the microbiome dysbiosis now occupies a particular place with implications for the determinism and clinical expression of CIRD, as well as the therapeutic response of affected patients. Several approaches exist to limit the impact of the microbiome during CIRD. This review aimed to present current strategies to prevent or reverse microbiome dysbiosis based on existing knowledge, in order to provide practical information to healthcare professionals treating patients suffering from CIRD.

Keywords: chronic inflammatory rheumatic diseases; dysbiosis; microbiome; prevention; sub-Saharan Africa; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1:
Figure 1:
Chronic inflammatory rheumatic diseases and mostly associated dysbiosis. AS: ankylosing spondylarthritis; IMM: idiopathic inflammatory myositis; PsA: psoriatic arthritis; RA: rheumatoid arthritis; ReA: reactive arthritis; SLE: systemic lupus erythematosus; SS: Sjögren’s syndrome; SSc: systemic sclerosis; Vasc: vasculitis.
Figure 2:
Figure 2:
Strategies for preventing and restoring dysbiosis in the microbiome.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Moutsopoulos HM. Autoimmune rheumatic diseases: One or many diseases? J Transl Autoimmun [Internet] 28 oct 2021;4. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716565/ - PMC - PubMed
    1. Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol avr 2014;10(4):212–28. - PMC - PubMed
    1. Vural M, Gilbert B, Üstün I, Caglar S, Finckh A. Mini-Review: Human Microbiome and Rheumatic Diseases. Front Cell Infect Microbiol [Internet] 10 nov 2020;10. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693548/ - PMC - PubMed
    1. Konig MF. The microbiome in autoimmune rheumatic disease. Connect Tissue Dis SLE. 1 févr 2020;34(1):101473. - PMC - PubMed
    1. Ford B. The story of the simple microscope: Heinemann. 1985;

LinkOut - more resources